|
|
|
Volumn 3, Issue 8, 2004, Pages 703-704
|
|
Cancer drug development and translational research are high priorities of special workshop
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR MARKER;
CANCER;
CANCER CELL;
CANCER GROWTH;
CANCER RESEARCH;
DNA DAMAGE;
DRUG APPROVAL;
GENETIC DAMAGE;
MOLECULAR MECHANICS;
NOTE;
SCIENCE;
ARTICLE;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
EDUCATION;
HUMAN;
METABOLISM;
NEOPLASM;
ORGANIZATION AND MANAGEMENT;
PHARMACEUTICS;
RESEARCH;
ANTINEOPLASTIC AGENTS;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
EDUCATION;
HUMANS;
NEOPLASMS;
RESEARCH;
TECHNOLOGY, PHARMACEUTICAL;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 15044357748
PISSN: 15384047
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|